22 May 2013
Keywords: reaferon, launch, japan, south, korea-based, dong, shin
Article | 03 April 1995
- South Korea-based Dong Shin Pharmaceutical has launched Reaferon
(alpha interferon) in Japan for the treatment of acute hepatitis B. The
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 April 1995
27 March 1995
10 April 1995
© 2013 thepharmaletter.com